To supply Aspart drug substance and expand patient access to Insulin Aspart in the US Biocon Biologics and Civica, Inc. (Civica), a not-for-profit generic drug and pharmaceutical company founded in ...

It was the end of 2020 when I received the news that I had been successful in securing my dream job – Head of School at King's College International School, Wuxi. I was both excited, and a ...

HCW Biologics (HCWB) reported that the Nasdaq Hearings Panel granted the company an extension in which to regain compliance with all continued listing rules of Nasdaq. The Panel’s determination ...

Is there such thing as too much honor? Not for Huxford Elementary School student Paisley Emmons. In Emmons’ short time on Earth, she’s managed to garner major accolades through her scholastic ...

BERKELEY, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Biomaterials company Marine Biologics today announced the launch of SuperCrude™, the world’s first programmable biomass. Designed from ...

WuXi Biologics has launched the E coli expression system, EffiX, designed to enhance the production of recombinant proteins and plasmid DNA (pDNA). The worldwide market for microbial-derived ...

Credit: Saiful52/Shutterstock. WuXi Biologics has launched the E coli expression system, EffiX, designed to enhance the production of recombinant proteins and plasmid DNA (pDNA). The worldwide market ...

As part of the partnership, Northway Biotech will apply its significant expertise in biologics manufacturing to develop a scalable GMP production process for Micreos' engineered endolysin technology.

PORTO, Portugal & SAN FRANCISCO--(BUSINESS WIRE)--FairJourney Biologics S.A., leaders in the discovery and optimization of antibodies, today announced that it had completed the acquisition of the ...

To address the challenges in producing these biomolecules, WuXi Biologics has introduced the EffiX™ platform, which enables the development and manufacturing of microbial-derived biologics with ...

To address the challenges in producing these biomolecules, WuXi Biologics has introduced the EffiX™ platform, which enables the development and manufacturing of microbial-derived biologics with high ...